Skip to Content

New Drug Approvals Archive - October 2002

October 2002

Pegasys (peginterferon alfa-2a) Injection

Date of Approval: October 16, 2002
Company: Hoffmann-La Roche
Treatment for: Chronic Hepatitis C

Pegasys (peginterferon alfa-2a) is a covalent conjugate of recombinant alfa-2a interferon indicated for the combination treatment of adults with chronic hepatitis C.

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.